Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure and action of bleomycin.

H Umezawa

    Progress in Biochemical Pharmacology
    |January 1, 1976
    PubMed
    Summary

    Bleomycin antibiotics

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Synthesis and antitumor activity of 4'-O-acylanthracyclines.

    The Journal of antibiotics·1992
    Same author

    Ascorbic acid and adriamycin toxicity.

    The American journal of clinical nutrition·1991
    Same author

    Synthesis of 3'-deoxy-3'-fluorokanamycin A and 3',4'-dideoxy-3'-fluorokanamycin A.

    Carbohydrate research·1991
    Same author

    High-performance liquid chromatographic determination of deoxyspergualin in dog plasma with ultraviolet detection.

    Journal of chromatography·1990
    Same author

    Post-ischaemic treatment with the prostacycline analogue TTC-909 reduces ischaemic brain injury.

    Acta neurochirurgica. Supplementum·1990
    Same author

    Local cerebral blood flow and glucose metabolism in hydrostatic brain oedema.

    Acta neurochirurgica. Supplementum·1990

    Area of Science:

    • Biochemistry
    • Pharmacology
    • Molecular Biology

    Background:

    • Bleomycins are a group of antibiotics with antitumor activity.
    • Their DNA-cleaving mechanism and toxicity profiles are complex and not fully understood.

    Purpose of the Study:

    • To elucidate the structural components of bleomycins responsible for DNA strand scission.
    • To investigate the relationship between bleomycin structure and its associated toxicities (renal and pulmonary).
    • To identify the bleomycin-inactivating enzyme and explore its role in therapeutic efficacy and toxicity.

    Main Methods:

    • Structural analysis of bleomycins and related compounds.
    • In vitro studies on SV40 viral DNA strand scission.
    • In vivo toxicity studies in dogs and mice.
    • Enzyme assays to characterize bleomycin-inactivating enzyme activity.
    • Cell growth inhibition assays with bleomycin and enzyme inhibitors.

    Main Results:

    • The beta-aminoalanine amide moiety and carbamoyl group are crucial for bleomycin's DNA strand scission activity.
    • Multiple guanido groups in terminal amines correlate with irreversible renal toxicity in dogs.
    • Pulmonary toxicity is dependent on specific terminal amine structures.
    • A novel aminopeptidase B was identified as the enzyme inactivating bleomycin by hydrolyzing the beta-aminoalanine amide group.
    • Lower levels of this enzyme in squamous cell carcinoma cells may contribute to bleomycin's efficacy against this cancer.
    • Inhibition of this enzyme potentiated bleomycin's anti-cancer effects, suggesting intracellular enzyme action.
    • Bleomycin 5033 demonstrated comparable efficacy and lower toxicity to current bleomycin treatments, while Bleomycin A5196 showed enhanced activity and toxicity but reduced lung toxicity.

    Conclusions:

    • Bleomycin's DNA-damaging activity is linked to specific structural features.
    • Terminal amine structure significantly influences bleomycin's dose-limiting toxicities.
    • Aminopeptidase B plays a key role in bleomycin inactivation and may be a target for modulating efficacy and toxicity.
    • Development of bleomycin derivatives with improved therapeutic indices, such as bleomycin 5033 and A5196, is promising.

    Related Experiment Videos